MSHFS 206 | Number | |
---|---|---|
Therapy | Neoadjuvant therapy | 67 |
Adjuvant therapy | 139 | |
First cycle dose (mg) | 70 | 3 |
60–69 | 64 | |
50–59 | 113 | |
40–49 | 25 | |
< 39 | 1 | |
MSHFS appearance cycle | 1 | 18 |
2 | 86 | |
3 | 78 | |
4 | 24 | |
Cumulative dose at the time of MSHFS (mg) | > 199 | 20 |
180–199 | 24 | |
160–179 | 18 | |
140–159 | 36 | |
120–139 | 26 | |
100–119 | 53 | |
80–99 | 11 | |
60–79 | 10 | |
40–59 | 8 | |
Reduce the dose (%) | 20% | 42 |
25% | 19 | |
Extension of time (Day) | 7 | 33 |
6 | 17 | |
5 | 39 |